Cogent Biosciences (COGT) Gains (Losses) on Sale of Assets & Investments (2018 - 2026)
Cogent Biosciences (COGT) posted Gains (Losses) on Sale of Assets & Investments of $23,000 for Q4 2020, compared with -$4,000 a year earlier and down 99.7% from the prior quarter.
Powered by 
Analysis
Cogent Biosciences (COGT) Gains (Losses) on Sale of Assets & Investments (2018 - 2026) Analysis & Trends
For FY2020, Cogent Biosciences' Gains (Losses) on Sale of Assets & Investments came in at $7.49 million.
- In prior years, Cogent Biosciences' Gains (Losses) on Sale of Assets & Investments was $78,000 in FY2019.
- Quarterly Gains (Losses) on Sale of Assets & Investments has run from a low of -$4,000 in Q4 2019 to a high of $7.46 million in Q3 2020 over five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gains on Sales (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Cogent Biosciences | 5.50 Bn | 2.15 Bn | - | 53,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 53,000.00 |
| Jun 30, 2026 | -355,000.00 |
| Mar 31, 2026 | -770,000.00 |
| Dec 31, 2025 | 147,000.00 |
| Sep 30, 2025 | 195,000.00 |
| Jun 30, 2025 | -151,000.00 |
| Mar 31, 2025 | -283,000.00 |
| Dec 31, 2024 | -449,000.00 |
| Sep 30, 2024 | 1.09 Mn |
| Jun 30, 2024 | -153,000.00 |
| Mar 31, 2024 | -285,000.00 |
| Dec 31, 2023 | 418,000.00 |
| Sep 30, 2023 | -75,000.00 |
| Jun 30, 2023 | -113,000.00 |
| Mar 31, 2023 | 120,000.00 |
| Dec 31, 2022 | 59,000.00 |
| Sep 30, 2022 | -163,000.00 |
| Dec 31, 2020 | 23,000.00 |
| Sep 30, 2020 | 7.46 Mn |
| Dec 31, 2019 | -4,000.00 |
API Access
Cogent Biosciences Gains (Losses) on Sale of Assets & Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=COGT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "COGT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=COGT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();